Literature DB >> 23246331

Evaluation of metabolic changes within the normal appearing gray and white matters in neurologically asymptomatic HIV-1-positive and HCV-positive patients: magnetic resonance spectroscopy and immunologic correlation.

Joanna Bladowska1, Anna Zimny, Anna Kołtowska, Paweł Szewczyk, Brygida Knysz, Jacek Gąsiorowski, Michał Furdal, Marek J Sąsiadek.   

Abstract

OBJECTIVE: The aim of the study was to evaluate early metabolic changes using proton MR spectroscopy (MRS) in asymptomatic HIV-1-positive and HCV-positive patients without abnormalities in the structural MR examination.
METHODS: Sixty-five asymptomatic patients: 21 HIV-1-positive naive, 20 HIV-1-positive with combination antiretroviral therapy (cART), 9 HIV-1/HCV-positive naive, 15 HCV-positive naive and 18 normal subjects were enrolled in the study. The MRS examinations were performed with a 1.5T MR scanner. Voxels were located in the following regions: posterior cingulate gyrus (PCG), anterior cingulate gyrus (ACG), parietal white matter (PWM), left basal ganglia (BG) and frontal white matter (FWM). The NAA/Cr, Cho/Cr, mI/Cr ratios and correlations of MRS measurements with the immunologic data were analyzed.
RESULTS: There was a significant decrease (p<0.05) of the NAA/Cr ratios in PCG, ACG and PWM regions in HIV-1-positive cART treated patients compared to the normal subjects. The significantly decreased NAA/Cr ratios in PWM and FWM were observed in HCV infected patients. The subjects with HIV-1/HCV co-infection revealed significantly lower NAA/Cr ratios in the ACG area. Other metabolite ratios in all analyzed regions, as well as the NAA/Cr ratios in BG showed no significant differences. The decrease of CD4n T cell count was associated with the decease of the NAA/Cr ratio in the PCG area and the increase of Cho/Cr ratio in the FWM region.
CONCLUSIONS: The metabolic changes - reduction of NAA/Cr ratios are most pronounced in HIV-1-positive patients using cART. The low CD4n T cell count is a risk factor for neurocognitive impairment in HIV-1-positive patients. Crown
Copyright © 2012. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23246331     DOI: 10.1016/j.ejrad.2012.11.029

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  20 in total

1.  Immunological and Neurometabolite Changes Associated With Switch From Efavirenz to an Integrase Inhibitor.

Authors:  Archana Asundi; Yvonne Robles; Tyler Starr; Alan Landay; Jennifer Kinslow; Joshua Ladner; Laura White; Rebeca M Plank; Kathleen Melbourne; Daniel Weisholtz; Monica Bennett; Hong Pan; Emily Stern; Alexander Lin; Daniel R Kuritzkes; Nina H Lin
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-15       Impact factor: 3.731

2.  Proton Chemical Shift Imaging Study of the Combined Antiretroviral Therapy Impact on Neurometabolic Parameters in Chronic HIV Infection.

Authors:  J Boban; D Kozic; V Turkulov; D Lendak; M Bjelan; M Semnic; S Brkic
Journal:  AJNR Am J Neuroradiol       Date:  2017-04-20       Impact factor: 3.825

Review 3.  Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain.

Authors:  Linda Chang; Sody M Munsaka; Stephanie Kraft-Terry; Thomas Ernst
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-12       Impact factor: 4.147

4.  Application of brain multi-b-value diffusion-weighted imaging (DWI) in adolescent orphans from AIDS families.

Authors:  Da-Zhen Jiang; Yang Zhong; Ding-Yi Zhou; Wei-Qing Wu; Guang-Yao Wu; Hong Quan
Journal:  Br J Radiol       Date:  2016-02-19       Impact factor: 3.039

5.  HIV-associated neurodegeneration and neuroimmunity: multivoxel MR spectroscopy study in drug-naïve and treated patients.

Authors:  Jasmina Boban; Dusko Kozic; Vesna Turkulov; Jelena Ostojic; Robert Semnic; Dajana Lendak; Snezana Brkic
Journal:  Eur Radiol       Date:  2017-03-14       Impact factor: 5.315

6.  Cerebral patterns of neuropsychological disturbances in hepatitis C patients.

Authors:  Tino Prell; Meike Dirks; Dimitrios Arvanitis; David Braun; Thomas Peschel; Hans Worthmann; Ramona Schuppner; Peter Raab; Julian Grosskreutz; Karin Weissenborn
Journal:  J Neurovirol       Date:  2019-01-04       Impact factor: 2.643

7.  Improvements in brain and behavior following eradication of hepatitis C.

Authors:  Taylor Kuhn; Philip Sayegh; Jacob D Jones; Jason Smith; Manoj K Sarma; A Ragin; Elyse J Singer; M Albert Thomas; April D Thames; Steven A Castellon; Charles H Hinkin
Journal:  J Neurovirol       Date:  2017-05-30       Impact factor: 2.643

Review 8.  Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015.

Authors:  Salvatore Monaco; Sara Mariotto; Sergio Ferrari; Massimiliano Calabrese; Gianluigi Zanusso; Alberto Gajofatto; Domenico Sansonno; Franco Dammacco
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.

Authors:  Napapon Sailasuta; Jintanat Ananworanich; Sukalaya Lerdlum; Pasiri Sithinamsuwan; James L K Fletcher; Somporn Tipsuk; Mantana Pothisri; Tanate Jadwattanakul; Supunnee Jirajariyavej; Thep Chalermchai; Stephanie Catella; Edgar Busovaca; Akash Desai; Robert Paul; Victor Valcour
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

10.  Form follows function: astrocyte morphology and immune dysfunction in SIV neuroAIDS.

Authors:  Kim M Lee; Kevin B Chiu; Nicole A Renner; Hope A Sansing; Peter J Didier; Andrew G MacLean
Journal:  J Neurovirol       Date:  2014-06-27       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.